Evidence map›Paper›PMID 42245267›Full record

ArticleFrontiers in artificial intelligence2026

A novel lightweight deep learning model for early prediction of cardiovascular disease.

Nasir Gul, Aurangzeb Khan, Mazliham Mohd Su'ud, Muhammad Mansoor Alam, Danyal Skandri

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nasir GulUniversity of Science and Technology, Bannu, Bannu, Pakistan.
Aurangzeb KhanUniversity of Science and Technology, Bannu, Bannu, Pakistan.
Mazliham Mohd Su'udFaculty of Computing and Informatics, Multimedia University, Cyberjaya, Malaysia.
Muhammad Mansoor AlamRiphah International University Information Services, Islamabad, Pakistan.
Danyal SkandriUniversity of Science and Technology, Bannu, Bannu, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular Disease (CVD) is still the main cause of death globally. Hence, to have timely clinical intervention, there is a need for the prediction of early risk models which are accurate and dependable. Here is a lightweight and strong artificial intelligence-based system for the early prediction of CVD using clinical data. We have created an end-to-end method comprising data preprocessing, stratified train and test splitting, and class imbalance treatment by SMOTE exclusively on the training set to ensure that there is no data leakage. We evaluate a series of machine learning (ML) and deep learning (DL) models, including Logistic Regression (LR), Decision Tree (DT), K-Nearest Neighbors (KNN), Random Forest (RF), Support Vector Machine (SVM), and various Artificial Neural Network (ANN) architectures, systematically. In order to check the robustness and generalizability of the models proposed, we conduct a k-fold cross-validation procedure and the performance measures are reported using evaluation matrices such as accuracy, precision, recall, F1-score, and ROC curve along with statistical metrics (mean and standard deviation). The results from the experiments show that the fine-tuned four-layer ANN yields the best prediction performance. Nevertheless, and in contrast to conventional studies, evaluation of the models is strongly based on robust validation and statistical reliability and not only on accuracy.

Indexed as

ANNCVDdeep learningmachine learningoversamplingrandom forestrisk prediction

Identifiers

PMID42245267
PMCPMC13229874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.